Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of the Korean Ophthalmological Society ; : 276-279, 2019.
Artigo em Coreano | WPRIM | ID: wpr-738608

RESUMO

PURPOSE: To report a case of corneal and lenticular pigmentation after prolonged clozapine therapy. CASE SUMMARY: A 56-year-old male visited our hospital with a progressive decline in vision that affected both eyes. He had a history of schizophrenia. He was being treated with 200 mg clozapine and 1 mg lorazepam daily, and had been treated with clozapine for 5 years. At the first visit, his best-corrected-visual acuity was 20/32 in both eyes. Slit lamp examination of the corneas showed bright, fine, grayish-brown deposits on the endothelium, and on dilation, bilateral central stellate opacity of the anterior portion of the lens capsule was revealed. CONCLUSIONS: Clozapine may induce corneal and lenticular pigmentation and thus may lead to a decline in vision. Patients on long-term clozapine therapy should be considered for regular ophthalmic review.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Clozapina , Córnea , Endotélio , Lorazepam , Pigmentação , Esquizofrenia , Lâmpada de Fenda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA